DIGITAL EDITION
GO TO CURRENT ISSUE - FREE!
> BUY > SUBSCRIBE > ARCHIVES  

SEPTEMBER 2010 • Contents

> GO TO THE TABLE OF CONTENTS

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Request Reprint Quote
Purchase Back Issue
Purchase PDF

PharmaVOICE
- June 2010

The Power of the Cloud
By Robin Robinson

    When Dave Powers, senior systems engineer, research and development IT at Eli Lilly and Company, talks about the advantages of cloud computing in the life-sciences industry, he gets pretty excited — as do others who have experienced first hand the benefits of the cloud. According to our thought leaders, cloud computing is game changing in the race to innovation, enabling scientists and technologists to quickly answer complicated analytical problems in record time and at record cost-savings.
    Lilly has validated the ability to move large scientific computing workloads online, or to the cloud, if you prefer. Among other initiatives, Lilly runs a 64-machine cluster computer working on bioinformatics sequence information that is able to reduce a 12-week processing time to 20 minutes. The speed is remarkable, and so is the cost: using Amazon’s EC2, the computer power costs all of about...

Sidebar:
The Cloud
Life-Sciences’ R&D Increasingly Adopts Cloud Computing Model
Proportion of Life-Sciences R&D Informatics Budgets Devoted to Cloud Computing

Cloud Service Levels

Experts on This Topic
Lynette Ferrara. Partner, CSC’s Health Informatics Practice, a global provider of technology-enabled business solutions. For more information, visit csc.com or e-mail Ms. Ferrara at gferrara@csc.com.
Michael Naimoli. U.S. Life Sciences ­Industry Solutions Director, Microsoft Corp., a provider of software, services, and ­solutions. For more information, visit microsoft.com.
Eric Olden. Founder and CEO, Symplified, a cloud security company that secures and optimizes Internet business by simplifying online identities and complex relationships. For more information, visit symplified.com.
Dave Powers. Senior Systems Engineer, Research and Development IT, Eli Lilly and ­Company, a Fortune 500 biopharmaceutical ­company, which is developing pharmaceutical products by applying the latest research from its own worldwide laboratories and from ­collaboration. For more information, visit lilly.com.
Jason Stowe. Founder and CEO, Cycle ­Computing, a provider of open-source, ­high-performance computing technology on internal desktops, servers, and in the cloud. For more information, visit cyclecomputing.com.
Matt Wallach. Executive VP and General ­Manager, Veeva Systems, which offers SaaS-based solutions for the global life-sciences industry. For more information, visit veevasystems.com.

WHAT’S THIS?
PDF:
Single-user watermarked PDF file. Copyright protected for your review only. This file cannot be used as a promotional or educational piece. If you are interested in an E-Print, request a Reprint Quote for pricing.
*Downloaded PDF files are not returnable or refundable.
Reprint:
A hard-copy reproduction of a specific article printed for promotional or educational use. These are printed in quantities of 100 to 2,500.
Back Issue:
A printed copy of an entire magazine. These are sold in unlimited quantities.


 

HBA Leadership

WebSeminars - Register Today!

PharmaVOICEMarketplace - Directory of Service Providers